ZYDUSLIFE.BO
Price:
$933.5
Market Cap:
$938.56B
Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, and internationally. It operates through Pharmaceuticals and Consumer Products segments. It offers finished dosage human formulations comprising generics, branded generics, and specialty formulations, including biosimilars and vaccines; active pharmaceutical ingredients; consumer wellness products; and products in the therapeutic areas of pain management, neurology, metabolic disorder, and liver diseases. The company offers the products under the Everyuth and Nutralite, Complan, Glucon D, and Nycil brands. In addition, the comp...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2002-07-01
Stock Exchange
BSE
Ticker
ZYDUSLIFE.BO
According to Zydus Lifesciences Limited’s latest financial reports and current stock price. The company's current PE Ratio is 19.09. This represents a change of -3.75% compared to the average of 19.83 of the last 4 quarters.
The mean historical PE Ratio of Zydus Lifesciences Limited over the last ten years is 21.20. The current 19.09 PE Ratio has changed 8.90% with respect to the historical average. Over the past ten years (40 quarters), ZYDUSLIFE.BO's PE Ratio was at its highest in in the June 2017 quarter at 97.25. The PE Ratio was at its lowest in in the September 2021 quarter at 4.70.
Average
21.20
Median
21.68
Minimum
7.95
Maximum
30.42
Discovering the peaks and valleys of Zydus Lifesciences Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 220.32%
Maximum Annual PE Ratio = 30.42
Minimum Annual Increase = -62.42%
Minimum Annual PE Ratio = 7.95
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 19.51 | -25.56% |
| 2024 | 26.21 | 2.93% |
| 2023 | 25.47 | 220.32% |
| 2022 | 7.95 | -62.42% |
| 2021 | 21.16 | -9.02% |
| 2020 | 23.25 | 21.98% |
| 2019 | 19.06 | -14.13% |
| 2018 | 22.20 | -27.02% |
| 2017 | 30.42 | 81.31% |
| 2016 | 16.78 | -45.88% |
The current PE Ratio of Zydus Lifesciences Limited (ZYDUSLIFE.BO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
23.73
5-year avg
20.06
10-year avg
21.20
Zydus Lifesciences Limited’s PE Ratio is greater than Dr. Reddy's Laboratories Limited (18.16), greater than Dr. Reddy's Laboratories Limited (18.16), less than Lupin Limited (22.07), less than Lupin Limited (22.07), less than Mankind Pharma Limited (51.75), less than Mankind Pharma Limited (51.75), less than Aurobindo Pharma Limited (20.44), less than Aurobindo Pharma Limited (20.44), less than Alkem Laboratories Limited (28.77), less than Alkem Laboratories Limited (28.77),
| Company | PE Ratio | Market cap |
|---|---|---|
| 18.16 | $1.06T | |
| 18.16 | $1.06T | |
| 22.07 | $957.17B | |
| 22.07 | $954.54B | |
| 51.75 | $906.23B | |
| 51.75 | $907.55B | |
| 20.44 | $699.46B | |
| 20.44 | $700.74B | |
| 28.77 | $679.19B | |
| 28.77 | $679.74B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zydus Lifesciences Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Zydus Lifesciences Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Zydus Lifesciences Limited's PE Ratio?
How is the PE Ratio calculated for Zydus Lifesciences Limited (ZYDUSLIFE.BO)?
What is the highest PE Ratio for Zydus Lifesciences Limited (ZYDUSLIFE.BO)?
What is the 3-year average PE Ratio for Zydus Lifesciences Limited (ZYDUSLIFE.BO)?
What is the 5-year average PE Ratio for Zydus Lifesciences Limited (ZYDUSLIFE.BO)?
How does the current PE Ratio for Zydus Lifesciences Limited (ZYDUSLIFE.BO) compare to its historical average?